 Faculty of Pharma Sciences, Teikyo University |
Lab page | Japanese | |
| Laboratory of Molecular Health Sciences | ||
|
|
||
 |
Publication List (Journals) | |
|
1.
|
Lysophosphatidylinositol induced morphological changes and stress fiber formation through the GPR55-RhoA-ROCK pathway; Nakajima K., Oka S., Tanikawa T., Nemoto-Sasaki Y, Matsumoto N., Ishiguro H., Arata Y., Sugiura T., Yamashita A., Int. J. Mol. Sci., 23, 10932 (2022) | |
|
2.
|
Expression and distribution of GPR55, a receptor for lysophosphatidylinositol, in mouse tissues and cells; Tanikawa T., Oka S., Nakajima K., Hayashi Y., Nemoto-Sasaki Y., Arata Y., Sugiura T. Yamashita A., BPB reports, 5, 16-20 (2022) | |
|
3.
|
Phosphorylation of human phospholipase A1 DDHD1 at newly identified phosphosites affects its subcellular localization; Matsumoto N., Nemoto-Sasaki Y., Oka S., Arai S., Wada I., Yamashita A.. J. Biol. Chem. 297, 100851 (2021) | |
|
4.
|
Osteoclast Differentiation Is Suppressed by Increased O-GlcNAcylation Due to Thiamet G Treatment; Takeuchi T., Horimoto Y., Oyama M., Nakatani S., Kobata K., Tamura M., Arata Y., Hatanaka T., Biol. Pharm. Bull., 43, 1501-1505 (2020) | |
|
5.
|
Expression, S-Nitrosylation, and measurement of S-Nitrosylation ratio of recombinant galectin-2; Tamura M., Arata Y., Methods in Molecular Biology, 2132, 55-63 (2020) | |
|
6.
|
Potential Interaction Between Galectin-2 and MUC5AC in Mouse Gastric Mucus;Tamura M., Tanaka T., Fujii N., Tanikawa T., Oka S., Takeuchi T., Hatanaka T., Kishimoto S., Arata Y.; Biol. Pharm. Bull., 43, 356-360 (2020). | |
|
7.
|
Galectin-2 has Bactericidal Effects against Helicobacter pylori in a β-galactoside-Dependent Manner; Sasaki T., Saito R., Oyama M., Takeuchi T., Tanaka T., Natsume H., Tamura M., Arata Y. Hatanaka T.; Int. J. Mol. Sci., 21, 2697 (2020) | |
|
8.
|
Galectin-2 suppresses nematode development by binding to the invertebrate-specific galactoseβ1-4fucose glyco-epitope; Takeuchi T., Tamura M., Ishiwata K., Hamasaki M., Hamano S., Arata Y., Hatanaka T.; Glycobiology, 29, 504-512 (2019). | |
|
9.
|
Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels; Hayashi Y., Nemoto-Sasaki Y., Matsumoto N., Hama K., Tanikawa T., Oka S., Saeki T., Kumasaka T., Koizumi T., Arai S., Wada I., Yokoyama K., Sugiura T., Yamashita A.; J. Biol. Chem. 293, 17505-17522 (2018) | |
|
10.
|
Structural mechanisms for the S-nitrosylation-derived protection of mouse galectin-2 from oxidation-induced inactivation revealed by NMR; Sakakura, M., Tamura, M., Fujii, N., Takeuchi, T., Hatanaka, T., Kishimoto, S., Arata, Y., Takahashi, H.; FEBS J. 285, 1129-1145 (2018) | |
|
11.
|
Identification of galectin-2-mucin interaction and possible formation of a high molecular weight lattice; Tamura, M., Sato, D., Nakajima, M., Saito, M., Sasaki, T., Tanaka, T., Hatanaka, T., Takeuchi, T., Arata, Y.; Biol. Pharm. Bull. 40, 1789-1795 (2017). | |
|
12.
|
Glucosamine suppresses osteoclast differentiation through the modulation of glycosylation including O-GlcNAcylation; Takeuchi, T., Sugimoto, A., Imazato, N., Tamura, M., Nakatani S., Kobata, K., Arata, Y.; Biol. Pharm. Bull. 40, 352-356 (2017) | |
|
13.
|
Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation. Yamashita, A., Hayashi, Y., Matsumoto, N., Nemoto-Sasaki, Y., Koizumi, T., Inagaki, Y., Oka, S., Tanikawa, T., Sugiura, T. Biology (Basel), 30, | |
|
14.
|
Carboxyl-terminal Tail-mediated Homodimerizations of Sphingomyelin Synthases Are Responsible for Efficient Export from the Endoplasmic Reticulum. Hayashi, Y., Nemoto-Sasaki, Y., Matsumoto, N., Tanikawa, T., Oka, S., Tanaka, Y., Arai, S., Wada, I., Sugiura, T., Yamashita, A. J. Biol. Chem., 292, 1122-1141 (2017) | |
|
15.
|
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. Peng, D., Tanikawa, T., Li, W., Zhao, L., Vatan, L., Szeliga, W., Wan, S., Wei, S., Wang, Y., Liu, Y., Staroslawska, E., Szubstarski, F., Rolinski, J., Grywalska, E., Stanis?awek, A., Polkowski, W., Kurylcio, A., Kleer, C., Chang, A.E., Wicha, M., Sabel, M., Zou, W., Kryczek, I. Cancer Res., 76, 3156-3165 (2016) | |
|
16.
|
Identification of the cysteine residue responsible for oxidative inactivation of mouse galectin-2. Tamura, M., Sasai, A., Ozawa, R., Saito, M., Yamamoto, K., Takeuchi, T., Ohtake, K., Tateno, H., Hirabayashi, J., Kobayashi, J. Arata, Y. J. Biochem. 160, 233-241 (2016) | |
|
17.
|
S-nitrosylation of mouse galectin-2 prevents oxidative inactivation by hydrogen peroxide. Tamura, M., Saito, M., Yamamoto, K., Takeuchi, T., Ohtake, K., Tateno, H., Hirabayashi, J., Kobayashi, J. Arata, Y. Biochem. Biophys. Res. Commun. 457, 712-717 (2015) | |
|
18.
|
Glycerophosphate/Acylglycerophosphate acyltransferases; Yamashita, A., Hayashi, Y., Matsumoto, N., Nemoto-Sasaki, Y., Oka, S., Tanikawa, T., Sugiura, T.; Biology (Basel), 3(4), 801-830 (2014) | |
|
19.
|
Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion; Hayashi, Y., Nemoto-Sasaki, Y., Tanikawa, T., Oka, S., Tsuchiya, K., Zama, K., Mitsutake, S., Sugiura, T., Yamashita, A.; J. Biol. Chem., 289(44), 30842-30856 (2014) | |
|
20.
|
Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms; Yamashita, A., Hayashi, Y., Nemoto-Sasaki, Y., Ito, M., Oka, S., Tanikawa, T., Waku, K., Sugiura, T.; Prog. Lipid Res., 53, 18-81 (2014) | |
|
21.
|
The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55; Yamashita, A., Oka, S., Tanikawa, T., Hayashi, Y., Nemoto-Sasaki, Y., Sugiura, T.; Prostaglandins Other Lipid Mediat., 107, 103-116 (2013) | |
|
22.
|
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation; Mimura, T., Oka, S., Koshimoto, H., Ueda, Y., Watanabe, Y., Sugiura, T.; Int. Arch. Allergy Immunol., 159(2), 149-156 (2012) | |
|
23.
|
GPR35 is a novel lysophosphatidic acid receptor; Oka, S., Ota, R., Shima, M., Yamashita, A. and Sugiura, T.; Biochem. Biophys. Res. Commun. 395, 232-237 (2010) | |
|
24.
|
Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1). Possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1; Yamashita, A, Kumazawa, T., Koga, H., Suzuki, N., Oka, S. and Sugiura, T.; Biochem. Biophys. Acta 1801, 711-720 (2010) | |
|
25.
|
Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells; Oka, S., Kimura, S., Toshida, T., Ota, R., Yamashita, A. and Sugiura, T.; J. Biochem. 147, 671-678. (2010) | |
|
26.
|
2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55; Oka, S., Toshida, T., Maruyama, K., Nakajima, K., Yamashita, A. and Sugiura, T.; J. Biochem. 145, 13-20 (2009) | |
|
27.
|
Subcellular localization and lysophospholipase/ transacylation activities of human group IVC phospholipase A2 (cPLA2γ); Yamashita A, Tanaka K, Kamata R, Kumazawa T, Suzuki N, Koga H, Waku K, Sugiura T.; Biochem. Biophys. Acta 1791, 1011-1022 (2009) | |
|
28.
|
Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand; Sugiura T.; Biofactors 35, 88-97 (2009) | |
|
29.
|
Identification of GPR55 as a lysophosphatidylinositol receptor; Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S. and Sugiura, T.; Biochem. Biophys. Res. Commun. 362: 928-934 (2007) | |
|
30.
|
Synthesis and biological evaluation of several structural analogs of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand; Suhara, Y., Oka, S., Kittaka, A., Takayama, H., Waku, K. and Sugiura, T.; Bioorg. Med. Chem. 15: 854-867 (2007) | |
|
31.
|
2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells; Gokoh, M., Kishimoto, S., Oka, S. and Sugiura, T.: Biol. Pharm. Bull. 30: 1199-1205 (2007) | |
|
32.
|
Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes; Oka, S., Arai, S., Waku, K., Tokumura, A. and Sugiura, T.: J. Biochem. 141: 687-697 (2007) | |
|
33.
|
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of endogenous ligand 2-arachidonoylglycerol; Oka, S., Wakui, J., Gokoh, M., Kishimoto, S., and Sugiura, T.: Eur. J. Pharmacol. 538 154-162 (2006) | |
|
34.
|
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants ; Kishimoto, S., Oka, S., Gokoh, M. and Sugiura, T.: Int. Arch. Allergy Immunol. 140 Suppl. 1, 3-7 (2006) | |
|
35.
|
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice; Oka, S., Wakui, J., Ikeda, S., Yanagimoto, S., Kishimoto, S. Gokoh, M., Nasui, M. and Sugiura, T.: J. Immunol. 177 8796-8805 (2006) | |
|
36.
|
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand ; Sugiura, T., Kishimoto, S., Oka, S. and Gokoh, M.: Prog. Lipid Res. 45 405-446 (2006) | |
|
37.
|
Endocannabinoid release by synaptic activity requires conjoint mGluR1-PLCb4 activation and Ca2+ elevation in cerebellum; Maejima, T., Oka, S., Hashimotodani, Y., Ohno-Shosaku, T., Aiba, A., Wu, D., Sugiura, T., and Kano, M.: J. Neurosci. 25 6826-6835 (2005) | |
|
38.
|
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces enhanced adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes; Gokoh, M., Kishimoto, S., Oka, S., Metani, Y., and Sugiura, T.: FEBS Lett. 579 6473-6478 (2005) | |
|
39.
|
Roles of C-terminal processing, and involvement in transacylation reaction of human group IVC phospholipase A2 (cPLA2gamma); Yamashita, A., Kamata, R., Kawagishi, N., Nakanishi, H., Suzuki, H., Sugiura, T., and Waku, K.: J. Biochem. 137 557-567 (2005) | |
|
40.
|
Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells; Kishimoto, S., Muramatsu, M., Gokoh, M., Oka, S., Waku, K., Sugiura, T.: J. Biochem. 137(2) 217-223 (2005) | |
|
41.
|
Evidence for the Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in 12-O-Tetradecanoylphorbol-13-acetate-induced Acute Inflammation in Mouse Ear; Oka, S., Yanagimoto, S., Ikeda, S., Gokoh, M., Kishimoto, S., Waku, K., Ishima, Y. and Sugiura, T.: J. Biol. Chem. 280(18) 18488-18497 (2005) | |
|
42.
|
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells; Gokoh, M., Kishimoto, S., Oka, S., Mori, M., Waku, K. Ishima, Y. and Sugiura, T.: Biochem. J. 386(Pt. 3) 583-589 (2005) | |
|
43.
|
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation; Sugiura, T., Oka, S., Gokoh, M., Kishimoto, S. and Waku, K.: J. Pharmacol. Sci. 96(4) 367-375 (2004) | |
|
44.
|
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils; Oka, S., Ikeda, S., Kishimoto, S., Gokoh, M., Waku, K. and Sugiura, T.: J. Leukoc. Biol. 76(5) 1002-1009 (2004) | |
|
45.
|
2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation; Fujishima, T., Kurihara, M., Kittaka, A., Saito, N., Honzawa, S., Kishimoto, S., Sugiura, T., Waku, K. and Takayama, H.: J. Steroid Biochem. Mol. Biol. 89-90(1-5) 89-92 (2004) | |
|
46.
|
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells; Kishimoto, S., Kobayashi, Y., Oka, S., Gokoh, M., Waku, K. and Sugiura, T.: J. Biochem. 135(4) 517-524 (2004) | |
|
47.
|
Efficient synthesis of 2-modified 1alpha, 25 dihyrdoxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells; Ono, K., Yoshida, A., Saito, N., Fujishima, T., Honzawa, S., Suhara, Y., Kishimoto, S., Sugiura, T., Waku, K., Takayama, H. and Kittaka, A.: J. Org. Chem. 68(19) 7407-7415 (2003) | |
|
48.
|
Concise synthesis and biological activities of 2alpha-alkyl- and 2alpha-(omega-hydroxyalkyl)-20-epi-1alpha-25-dihydroxyvitamin D3; Honzawa, S., Suhara, Y., Nihei, K., Saito, N., Kishimoto, S., Fujishima, T., Kurihara, M., Sugiura, T., Waku, K., Takayama, H. and Kittaka, A.: Bioorg. Med. Chem. Lett. 13(20) 3503-3506 (2003) | |
|
49.
|
Reverse reaction of lysophosphatidylinositol asyltransferase. Functional reconstitution of coenzyme A-dependent transaylation system; Yamashita, A., Watanabe, M., Sato, K., Miyasita, T., Nagatuka., T, Kondo, H., Kawagishi, N., Nakanishi, H., Kamata, R., Sugiura, T. and Waku, K.: J. Biol. Chem. 278(32) 30382-30393 (2003) | |
|
50.
|
Ether-linked analog of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species; Oka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K. and Sugiura, T.: J. Neurochem. 85(6) 1374-1381 (2003) | |
|
51.
|
2-Arachidonoylglycerol Induces the Migraton of HL-60 Cells Differentiated into Macrophage-like Cells through the Cannabinoid CB2 Receptor-Dependent Mechanism; Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K. and Sugiura, T.: J. Biol. Chem. 278(27) 24469-24475 (2003) | |
|
52.
|
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.; Sugiura, T., Nakane, S., Kishimoto, S., Waku, K., Yoshioka, Y. and Tokumura, A.: J. Lipid Res. 43, 2049-2055 (2003) | |
|
53.
|
Synthesis and Testing of 2a-Modified 1a,25-Dihydroxyvitamin D3 Analogues with a Double Side Chain: Marked Cell Differentiation Activity.; Suhara, Y., Kittaka, A., Kishimoto, S., Calverley, M. J., Fujishima, T., Saito, N., Sugiura, T., Waku, K. and Takayama, H.: Bioorg. Med. Chem. Lett. 12 3255-3258 (2002) | |
|
54.
|
Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea pig distal colon in vitro.; Kojima, S., Sugiura, T., Waku, K. and Kamikawa, Y.: Eur. J. Pharmacol. 444(3) 203-207 (2002) | |
|
55.
|
2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain.; Nakane, S., Oka, S., Arai, S., Waku, K., Ishima, Y., Tokumura, A. and Sugiura, T.: Arch. Biochem. Biophys. 402(1), 51-58 (2002) | |
|
56.
|
Cannabinoid receptors and their endogenous ligands.; Sugiura, T. and Waku, K.: J. Biochem. 132(1) 7-12 (2002) | |
|
57.
|
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.; Sugiura, T., Kobayashi, Y., Oka S., and Waku, K.: Prostaglandins Leukot. Essent. Fatty Acids 66(2-3) 173-192 (2002) | |
|
58.
|
Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.; Tokumura, A., Sinomiya, J., Kishimoto, S., Tanaka, T., Kogure, K., Sugiura, T., Satouchi, K., Waku, K. and Fukuzawa, K.: Biochem. J. 365(Pt. 3) 617-628 (2002) | |
|
59.
|
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves.; Kurihara, J., Nishigaki, M., Suzuki, S., Okubo, Y., Takata, Y., Nakane, S., Sugiura, T., Waku, K. and Kato, H.: Jpn. J. Pharmacol. 87 93-96 (2001) | |
|
60.
|
2-Arachidonoylglycerol, a candidate of endothelium-drived hyperpolarizing factor.; Kagota, S., Yamaguchi, Y., Nakamura, K., Sugiura, T., Waku, K. and Kunitomo, M.: Eur. J. Pharmacol. 415 233-238 (2001) | |
|
61.
|
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.; Yamaguchi, T., Hagiwara, Y., Tanaka, H., Sugiura, T., Waku, K., Shoyama, Y., Watanabe, S. and Yamamoto, T.: Brain Res. 909 121-126 (2001) | |
|
62.
|
Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells.; Kobayashi, Y., Arai, S., Waku, K. and Sugiura, T.: J. Biochem. 129 665-669 (2001) | |
|
63.
|
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.; Suhara, Y., Nakane, S., Arai, S., Takayama, H., Waku, K., Ishima, Y. and Sugiura, T.: Bioorg. Med. Chem. Lett. 11 1985-1988 (2001) | |
|
64.
|
ATP-independent fatty acyl-coenzyme a synthesis from phospholipid.; Yamashita, A., Kawagishi, N., Miyashita, T., Nagatsuka, T., Sugiura, T., Kume, K., Shimizu, T. and Waku, K.: J. Biol. Chem. 276 26745-26752 (2001) | |
|
65.
|
Hen egg yolk and white contain high amounts of lysophosphatidic acid, growth factor-like lipids: distinct molecular species compositions.; Nakane, S., Tokumura, A., Waku, K. and Sugiura, T.: Lipids 36 413-419 (2001) | |
|
66.
|
2-Aradhidonoylglycerol: an endogenous cannabinoid receptor agonist.; Sugiura, T. and Waku, K.: World Rev. Nutr. Diet. 88 200-206 (2001) | |
|
67.
|
Leptin-regulated endocannabinoids are involved in maintaining food intake.; Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G. I., Palmiter, R.D., Sugiura, T. and Kunos, G.: Nature 410(6830) 822-825 (2001) | |
|
68.
|
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation.; Sugiura, T., Yoshinaga, N. and Waku, K.: Neurosci. Lett. 297 175-178 (2001) | |
|
69.
|
2-Arachidonoylglycerol and the cannabinoid receptors.; Sugiura, T. and Waku, K.:Chem. Phys. Lipids 108 89-106 (2000) | |
|
70.
|
Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues.; Suhara, Y., Takayama, H., Nakane, S., Miyashita, T., Waku, K. and Sugiura, T.: Chem. Pharm. Bull. 48(7) 903-907 (2000) | |
|
71.
|
Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain.; Sugiura, T., Yoshinaga, N., Kondo, S., Waku, K. and Ishima, Y.: Biochem. Biophys. Res. Commun. 271(3) 654-658 (2000) | |
|
72.
|
2-arachidonoylglycerol: a possible multifunctional lipid mediator in the nervous and immune systems.; Sugiura, T. and Waku, K.: Ann. N.Y. Acad. Sci. 905 344-346 (2000) | |
|
73.
|
Acyl and alkyl ether-linked lysophosphatidic acids in the nervous system.; Sugiura, T., Waku, K. and Tokumura, A.: Ann. N.Y. Acad. Sci. 905 351-353 (2000) | |
|
74.
|
Occurrence of a novel cannabimimetic molecule 2-sciadonoylglycerol (2-eicosa-5',11',14'-trienoylglycerol) in the umbrella pine sciadopitys verticillata seeds.; Nakane, S., Tanaka, T., Satouchi, K., Kobayashi, Y., Waku, K. and Sugiura, T.: Biol. Pharm. Bull. 23(6) 758-761 (2000) | |
|
75.
|
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor.; Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H. and Waku, K.: J. Biol. Chem. 275(1) 605-612 (2000) | |
|
76.
|
Peroxisomal membrane protein pmp47 is essential in the metabolism of middlw-chain fatty acid in teast peroxisomes and is associated with peroxisome proliferation.; Nakagawa, T., Imanaka, T., Morita, M., Ishiguro, K., Yurimoto, H., Yamashita, A., Kato, N. and Sakai, Y.: J. Biol. Chem. 275(5) 3455-3461 (2000) | |
|
77.
|
Cardiovascular effects of 2-arachidonoylglycerol in anesthetized mice.; Jarai, Z., Wagner, J. A., Goparaju, S. K., Ranzdan, R. K., Sugiura, T., Zimmer, A. M., Bonner, T. I., Zimmer A. and Kunos, G.: Hypertension 35(2) 679-684 (2000) | |
|
78
|
Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells.; Sugiura, T., Nakane, S., Kishimoto, S., Waku, K., Yoshioka, Y., Tokumura, A. and Hanahan, D. J.:Biochim. Biophys. Acta 1440 194-204 (1999) | |
|
79.
|
Characterization of the 70-kDa peroxisomal membrane protein, an ATP binding cassette transporter.; Imanaka, T., Aihara, K., Takano, T., Yamashita, A., Sato, R., Suzuki, Y., Yokota, S. and Osumi, T.: J. Biol. Chem. 274(17) 11968-11977 (1999) | |
|
80.
|
Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor: structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues and related compounds.; Sugiura, T., Kodaka, T., Nakane, S., Mayashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N. and Ishima, Y.: J. Biol. Chem. 274 2794-2801 (1999) | |
|
81.
|
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivat by nervous and peripheral cells: connections with anandamide.; Di Marzo, V., Bisogno, T., Sugiura, T., Melck, D. and De Petrocellis, L.: Biochem. J. 331 15-19 (1999) | |
|
82.
|
Non-methylene-interrupted polyunsaturated fatty acids: effective substitute for arachidonate of phosphatidylinositol.; Tanaka, T., Takimoto, T., Morishige, J., Kikuta, Y., Sugiura, T. and Satouchi, K.: Biochem. Biophys. Res. Commun. 264 683-688 (1999) | |
|
Publication List (Books and others) | |
|
1.
|
T. Sugiura, S. Oka, S. Ikeda, K. Waku, Occurrence, biosynthesis and metabolism of endocannabinoids, pp. 177-214, Endocannabinoids, edited by E. Onaivi, T. Sugiura and V. Di Marzo, CRC Press, Boca Raton. 2006 | |
|
2.
|
S. Oka, Y. Ishima, K. Waku, and T. Sugiura, Endocannabinoids as retrograde messengers in the synaptic transmission. pp. 133-149, Endocannabinoids, edited by E. Onaivi, T. Sugiura and V. Di Marzo, CRC Press, Boca Raton, 2006 | |
|
3.
|
T. Sugiura, S. Oka, M. Gokoh and K. Waku, Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in neuromodulation and inflammation., pp. 97-118, Recent Advances in Pharmacology and Physiology of Cannabinoids, T. Wenger ed., Research Signpost, India, 2004 | |
|
4.
|
T. Sugiura, S. Kishimoto, S. Oka, M. Gokoh and K. Waku, Metabolism and physiological significance of anandamide and 2-arachidonoylglycerol, endogenous cannabinoid receptor ligands., pp. 211-237, Arachidonate Remodeling and Inflammation, A.F. Fonteh and R.L. Wykle eds., Birkhauser Verlag Basel, Switzerland, 2004 | |
|
5.
|
T. Sugiura and K. Waku, Biosynthesis of platelet-activating factor and structurally related bioactive lipids., pp. 285-302, Comprehensive NaturalProducts Chemistry, D. Barton and K. Nakanishi, Elsevier, Amsterdam, 1999 | |
|
6.
|
T. Sugiura, S. Kondo, T. Kodaka, S. Nakane, A. Yamashita, S. Kishimoto,K. Waku and Y. Ishima, Biosynthesis and actions of anandamide and2-arachidon oylglycerol, endogenous cannabimimetic molecules., pp. 380-384,Essential Fatty Acids and Eicosanoids, R. A. Riemersma, R. Armstrong, W.Kelly, R. Wilsoneds. eds., AOCS Press, Champaign, 1998 | |
|
7.
|
T. Sugiura, T. Fukuda, T. Miyamoto, N-N. Cheng. and K. Waku,Biosynthesis, metabolic fate, and actions of platelet-activating factor in the lower animals., pp.167-178, Platelet-activating factor, Signal Mechanisms and Molecular Biology, S. D. Shukla, ed., CRC Press, 1993 | |
|
8.
|
Y. Nakagawa and K. Waku, Phospholipids., pp.149-178, Neuromethod Vol. 8, Lipid and Related Compounds, Horrocks, L. A., ed., Humana Press, 1988 | |
|
9.
|
Y. Nakagawa. and K. Waku, HPLC of the arachidonoyl molecular species of glycerophospholipids in alveolar macrophages and immune responses., pp.163-190, Chromatography of Lipids in Biomedical Research and Clinical Diagnosis, A. Kuksis, ed., Elsevier Science Publishers B. V., 1987 | |
|
10.
|
T. Sugiura and K. Waku, Composition of alkyl ether-linked phospholipids in mammalian tissues., pp.55-85, Platelet-Activating Factor and Related Lipid Mediators, Snytder, F., ed., Plenum Press, 1987 | |
|
11.
|
T. Sugiura, Y. Nakagawa and K. Waku, Metabolism of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: a putative source of potent lipid mediators in macrophages., pp.45-50, New Horizons in PAF Research, M. L. Lee and C.M. Winslow, eds., John Wiley and Sons, 1987 | |
|
12.
|
K. Waku, T. Sugiura, Y. Nakagawa, Metabolism of 1-O-alkyl-2-acyl- sn-glycero-3-phosphocholine: a precursor of platelet-activating factor in macrophages., pp.697-699, Advances in Prostaglandin, Thromboxane and Leukotriene Research, Vol. 15, O. Hayaishi and S. Yamamoto, eds., Raven Press, 1985 | |
|
|
||